Physio-Control
| File:PhysioControl-logo2008.jpg Logo circa 2008 | |
| Formerly | Physio-Control Corporation
Medtronic Physio-Control Medtronic Emergency Response Systems |
|---|---|
| Industry | Medical equipment |
| Founded | 1955 |
| Founder | Dr. Karl William Edmark |
| Headquarters | Redmond, Washington, U.S. |
Key people | Anne Mullally, GM and VP |
| Products | Medical equipment for prehospital, hospital emergency, and military cardiac care |
| Parent | Stryker Corporation |
| Website | www.physio-control.com |
Physio-Control was established in 1955 by Dr. Karl W. Edmark and became a leader in portable defibrillation technology. The firm specializes in manufacturing emergency defibrillators and automated CPR devices. Since its acquisition by Stryker Corporation in 2016, it has operated as part of Stryker's Emergency Care segment.
History
Physio-Control originated in 1955 when Dr. Edmark founded the company to commercialize his "Heartbeat Indicator," an early device designed to monitor cardiac activity. He subsequently invented the first DC Defibrillator, which replaced the older high-voltage AC models with a safer, controlled low-voltage shock, minimizing injury during cardiac interventions.
In 1968, the company launched the Lifepak 33—a portable defibrillator weighing just 34 pounds—considerably lighter than competing models. This device was adopted by various users, including the United States Navy, which equipped Air Force One and Two with it.
The company went public in 1971 before being acquired by Eli Lilly and Company in 1980 for about $145 million, providing early investors with significant profits.
Following an FDA inspection in 1992 that uncovered production shortcomings, Physio-Control temporarily ceased manufacturing to resolve regulatory compliance issues.
Bain Capital purchased the company in 1994 for $23.3 million, appointing Steve Pagliuca as chairman. Later, Medtronic acquired Physio-Control in 1998 for $538 million, operating it initially as Medtronic Physio-Control and subsequently as Medtronic Emergency Response Systems.
In 2003, the firm introduced the LUCAS CPR device—a mechanical chest compression system powered pneumatically—that improved CPR delivery and became widely used by emergency responders.
Although Medtronic considered spinning off the business in 2006, Physio-Control remained within its portfolio until Bain Capital reacquired it in 2011 for $487 million, maintaining its independent operation.
Stryker Corporation purchased Physio-Control in 2016 for $1.28 billion. Following this acquisition, the LUCAS 3.1 mechanical CPR device was released under Stryker’s branding.
By 2022, Physio-Control operates as a wholly owned subsidiary of Stryker focused on product development and manufacturing, while Stryker oversees distribution activities.
In 2024, Physio-Control introduced the LIFEPAK 35 Monitor/Defibrillator as its latest flagship offering.
Products
Physio-Control’s product range centers on emergency interventions for sudden cardiac arrest. The Lifepak series includes sophisticated defibrillators designed for use by trained healthcare professionals alongside automated external defibrillators (AEDs) intended for first responders and public use. The company also markets the LUCAS automated chest compression system, utilized both on-site and within hospital settings to maintain circulation during resuscitation efforts. Additionally, Physio-Control developed the TrueCPR feedback device aimed at enhancing CPR performance quality.
Noteworthy Applications and Clients
Lifepak units, particularly the 12 and 15 models, are commonly showcased in medical television dramas due to their versatile large display screens. In August 2008, NASA installed a Lifepak 1000 AED on the International Space Station, which was brought back in 2011. Although Physio-Control asserts that NASA also utilized a Lifepak 8, there is no independent confirmation of this claim.
The New South Wales Ambulance (NSW Ambulance), ranking as the third-largest ambulance service globally, employs more than 1,000 Lifepak 15 defibrillators. Historically, their general duty teams used a combination of ZOLL M-Series monitors and Lifepak 10 devices, while Intensive Care Paramedics relied on Lifepak 12 units for advanced diagnostic capabilities. NSW Ambulance is currently implementing LUCAS 3 devices across its fleet to enhance the effectiveness of mechanical CPR.
Similarly, the East Midlands Ambulance Service (EMAS) utilizes Lifepak 15 defibrillators, with many of its vehicles equipped with LUCAS devices. Numerous ambulance providers throughout the United States depend on Lifepak monitor/defibrillators; however, comprehensive market share information is scarce due to the industry's fragmented nature.
2022 Integration with Stryker
In 2022, six years following Stryker’s acquisition of Physio-Control, the company introduced the latest LIFEPAK 15 V4+ model featuring Stryker branding instead of Physio-Control’s logo. At the same time, most former Physio-Control websites—excluding "lucas-cpr.com"—were redirected to Stryker’s Emergency Care portal. On social media platforms, Physio-Control is identified as "Physio-Control, Now part of Stryker" to highlight the merger. Despite this transition, Physio-Control continues to operate as a wholly owned subsidiary of Stryker, responsible for designing and manufacturing products distributed through Stryker Emergency Care.